Trial | NCT02201134  Report issue

Official Title

SEVOflurane Inhalation in CARdiac Arrest Resuscitated Patients Treated With Therapeutic Hypothermia

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Unknown status

  • Study Participants

    18
Studying the feasibility of an initial sedation with inhalated sevoflurane during therapeutic hypothermia of cardiac arrests resuscitated patients.
Prospective clinical study in ICU with ventilated patients sedated with sevoflurane using the Mirus® and Anaconda® , establishing the feasibility of an initial sedation of patients resuscitated from cardiac arrest and treated with therapeutic hypothermia.
Study Started
Jul 31
2014
Primary Completion
Dec 31
2016
Anticipated
Study Completion
Dec 31
2016
Anticipated
Last Update
Jul 29
2016
Estimate

Drug sevoflurane

sevoflurane Other

Criteria 

Inclusion Criteria:

-Adult patients ventilated requiring therapeutic hypothermia in ICU
Stable respiratory and hemodynamic conditions
Epinephrine and norepinephrine infusion rate < 1,5 g/kg/min
Consent of patients or family
Arterial line
Patients resuscitated after cardiac arrest
No Flow < 10 min
Low Flow < 20 min
Neutropenia < 1 G/L
Post traumatic cardiac arrest
Contraindication of halogenated anesthesics
Extra corporeal life support or intra aortic balloon pump

Exclusion Criteria:

-Pregnant woman
Hemodynamic instability
Brain death defined by the disappearance of brain stem reflexes
No Results Posted